Cargando…

Stable HIV‐1 reservoirs on dolutegravir maintenance monotherapy: the MONODO study

OBJECTIVES: Dolutegravir (DTG) is a highly effective integrase inhibitor with a strong genetic resistance barrier and a potential role in simplified HIV maintenance treatment. We assessed the feasibility of DTG maintenance monotherapy and measured HIV reservoirs on DTG monotherapy. METHODS: An inter...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sculier, D, Doco‐Lecompte, T, Yerly, S, Metzner, KJ, Decosterd, LA, Calmy, A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Short Communications
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6120531/ https://www.ncbi.nlm.nih.gov/pubmed/29932298 http://dx.doi.org/10.1111/hiv.12626

Ejemplares similares

Predictors of virological failure in HIV‐1‐infected patients switching to dolutegravir maintenance monotherapy
por: Wijting, IEA, et al.
Publicado: (2018)

Efficacy and safety of dolutegravir plus emtricitabine versus standard ART for the maintenance of HIV-1 suppression: 48-week results of the factorial, randomized, non-inferiority SIMPL’HIV trial
por: Sculier, Delphine, et al.
Publicado: (2020)

Haemophagocytic syndrome and elevated EBV load as initial manifestation of Hodgkin lymphoma in a HIV patient: case report and review of the literature
por: Sculier, Delphine, et al.
Publicado: (2014)

Virologic failure and HIV drug resistance on simplified, dolutegravir-based maintenance therapy: Systematic review and meta-analysis
por: Wandeler, Gilles, et al.
Publicado: (2019)

Dolutegravir Monotherapy as Maintenance Strategy: A Meta-Analysis of Individual Participant Data From Randomized Controlled Trials
por: Fournier, Anna L, et al.
Publicado: (2022)

Safety and Efficacy of Dolutegravir Plus Rilpivirine in Treatment-Experienced HIV-Infected Patients: The DORIVIR Study
por: Palacios, Rosario, et al.
Publicado: (2018)

Dolutegravir-Based Antiretroviral Regimens for HIV Liver Transplant Patients in Real-Life Settings
por: Cattaneo, Dario, et al.
Publicado: (2020)

Adverse events of raltegravir and dolutegravir
por: Elzi, Luigia, et al.
Publicado: (2017)

Effect of Rifabutin in Dolutegravir Dosing: A Case Series
por: Mendoza, Maria A., et al.
Publicado: (2022)

Lipohypertrophy and metabolic disorders in HIV patients on antiretroviral therapy: a systematic multidisciplinary clinical approach
por: Sculier, Delphine, et al.
Publicado: (2014)

Absence of Proviral Human Immunodeficiency Virus (HIV) Type 1 Evolution in Early-Treated Individuals With HIV Switching to Dolutegravir Monotherapy During 48 Weeks
por: Jörimann, Lisa, et al.
Publicado: (2023)

7‐Step Flow Synthesis of the HIV Integrase Inhibitor Dolutegravir
por: Ziegler, Robert E., et al.
Publicado: (2018)

In vitro activity of dolutegravir against wild-type and integrase inhibitor-resistant HIV-2
por: Smith, Robert A, et al.
Publicado: (2015)

Dual therapy with renally adjusted lamivudine and dolutegravir: a switch strategy to manage comorbidity and toxicity in older, suppressed patients?
por: Tan, M, et al.
Publicado: (2019)

Dolutegravir-based antiretroviral therapy in a severely overweight child with a multidrug-resistant human immunodeficiency virus infection. A case report and review
por: Wagner, N., et al.
Publicado: (2015)

Heritability of the HIV-1 reservoir size and decay under long-term suppressive ART
por: Wan, Chenjie, et al.
Publicado: (2020)

Facilitators and barriers of women's participation in HIV clinical research in Switzerland: A qualitative study
por: Courvoisier, Nelly, et al.
Publicado: (2022)

Impact of the M184V/I Mutation on the Efficacy of Abacavir/Lamivudine/Dolutegravir Therapy in HIV Treatment-Experienced Patients
por: Olearo, Flaminia, et al.
Publicado: (2019)

Evaluation of the HBV liver reservoir with fine needle aspirates
por: Testoni, Barbara, et al.
Publicado: (2023)

First Use of Tapinarof Monotherapy for Seborrhoeic Dermatitis: A Case Report
por: ISSA, Naiem T., et al.
Publicado: (2023)

Corrigendum to: Impact of the M184V/I Mutation on the Efficacy of Abacavir/Lamivudine/Dolutegravir Therapy in HIV Treatment-Experienced Patients
por: Olearo, Flaminia, et al.
Publicado: (2019)

Bats and birds as viral reservoirs: A physiological and ecological perspective
por: Nabi, Ghulam, et al.
Publicado: (2021)

Viral suppression after transition from nonnucleoside reverse transcriptase inhibitor‐ to dolutegravir‐based antiretroviral therapy: A prospective cohort study in Lesotho (DO‐REAL study)
por: Brown, Jennifer A., et al.
Publicado: (2021)

Dolutegravir is not associated with weight gain in antiretroviral therapy experienced geriatric patients living with HIV
por: Guaraldi, Giovanni, et al.
Publicado: (2021)

The role of dolutegravir in the management of HIV infection
por: Miller, Misty M, et al.
Publicado: (2015)

Pyroptosis, superinfection, and the maintenance of the latent reservoir in HIV-1 infection
por: Wodarz, Dominik, et al.
Publicado: (2017)

Construction of Stable T7 Expression System in Saccharomyces cerevisiae by Improving Nuclear Membrane Permeability with Viroporin HIV-1 Vpu
por: Yan, Kun, et al.
Publicado: (2021)

High rates of transmitted NNRTI resistance among persons with acute HIV infection in Malawi: implications for first-line dolutegravir scale-up
por: Rutstein, Sarah E., et al.
Publicado: (2019)

Corrigendum to “Dolutegravir-based antiretroviral therapy in a severely overweight child with a multi-drug resistant human immunodeficiency virus infection. A case report and review” [New Microbes New Infect] 6 (2015) 1–4]
por: Wagner, N., et al.
Publicado: (2015)

Urinary Schistosomiasis around Oyan Reservoir, Nigeria: Twenty Years after the First Outbreak
por: Akinwale, OP, et al.
Publicado: (2010)

Wild deer in the United Kingdom are a potential reservoir for the livestock parasite Babesia divergens
por: Gray, Alexander, et al.
Publicado: (2021)

Dental calculus—a reservoir for detection of past SARS-CoV-2 infection
por: Berton, Federico, et al.
Publicado: (2021)

Efficacy and safety of immune checkpoint inhibitor monotherapy in elderly patients with non‐small cell lung cancer
por: Chikaishi, Yasuhiro, et al.
Publicado: (2021)

Impact of monotherapy on HIV-1 reservoir, immune activation, and co-infection with Epstein-Barr virus
por: Petrara, Maria Raffaella, et al.
Publicado: (2017)

Potential effects of anthropogenic noise on echolocation behavior in horseshoe bats
por: Hage, Steffen R., et al.
Publicado: (2013)

Dolutegravir-based monotherapy or dual therapy maintains a high proportion of viral suppression even in highly experienced HIV-1-infected patients
por: Gubavu, Camelia, et al.
Publicado: (2016)

A reflective process led by a family physician to develop a renal-protection surveillance tool for HIV patients newly started on dolutegravir
por: Omar, Junaid, et al.
Publicado: (2021)

Longitudinal Progression of Subclinical Coronary Atherosclerosis in Swiss HIV-Positive Compared With HIV-Negative Persons Undergoing Coronary Calcium Score Scan and CT Angiography
por: Tarr, Philip E, et al.
Publicado: (2020)

Clinical effectiveness of dolutegravir in the treatment of HIV/AIDS
por: Taha, Huda, et al.
Publicado: (2015)

Dolutegravir/rilpivirine for the treatment of HIV-1 infection
por: Dowers, Ellen, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_4fulsfegs80f1i9pmq7asv6qtj